Mecillinam (parenteral)

Generic name
Mecillinam (parenteral)
Brand name
ATC Code
J01CA11

Mecillinam (parenteral)

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information is present at this moment.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Urinary tract infections
  • Intravenous
    • 1 month up to 18 years
      • 20 - 40 mg/kg/day in 3 - 4 doses.

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects in children

Limited data. The adverse reaction profile in children is expected to be similar to that in adults.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

BETA-LACTAM ANTIBACTERIALS, PENICILLINS

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Penicillins with extended spectrum
J01CA04
J01CA01
J01CA08
Beta-lactamase sensitive penicillins
J01CE08
J01CE01
J01CE05
J01CE02
J01CE10
Beta-lactamase resistant penicillins
J01CF01
J01CF05
J01CF02
J01CF02
Combinations of penicillins, incl. beta-lactamase inhibitors
J01CR02
J01CR01, J01CR04
J01CR05
J01CR04

Reference

  1. Karo Pharma AB, SPC Selexid pulver til injeksjonsvæske (07-5342). Oppdateringsdato: 25.11.2019., https://www.legemiddelsok.no/_layouts/15/Preparatomtaler/Spc/07-5342.pdf

Changes

Therapeutic Drug Monitoring


Overdose